Partnership will expand Evotec’s molecular patient database in the area of metabolic diseases and in particular obesity.

Fluidic Sciences Ltd., announces its official launch as a company, and the commercial relaunch of the acquired Fluidity One-M instrument for measuring protein-protein interactions in solution—leveraging Microfluidic Diffusional Sizing (MDS) technology.

Codexis, Inc. (NASDAQ: CDXS), announced it has successfully synthesized an oligonucleotide via an enzymatic route to support RNA-based therapeutics manufacturing.

NEOsphere Biotechnologies GmbH, a German biotechnology company pioneering high-throughput proteomics to systematically build broad and unique portfolios of novel degrader targets at scale, announced a collaboration with Kymera Therapeutics, Inc.

The collaborative center will help to lower barriers to RNA innovation and discovery.

Scottish CRDMO Ingenza has secured innovation funding to adapt its codABLE® machine learning platform to precisely control recombinant protein expression in the industrial yeast Pichia pastoris.

Nuclera, announced it has successfully completed 11 installs of its eProtein Discovery™ system, including at leading academic institutes.

Sino Biological, Inc. ("Sino Biological" or the "Company”), has successfully concluded its acquisition of Vancouver-based Canadian biotechnology company SignalChem Biotech Inc.

TriLink BioTechnologies (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) has announced the grand opening of its new cGMP mRNA manufacturing facility.

Collaboration aims to grow clinical evidence supporting the use of bio-Rad’s ddPCR™ technology for molecular residual disease monitoring of patients across a range of solid tumor types.